Ultragenyx Pharmaceutical, Inc. · Bedford, Massachusetts
Case #I-200-25022-634122
Ultragenyx Pharmaceutical, Inc. filed an H-1B petition for a Assoc. Director, Technical Project Management - Gene Therapy position in Bedford, Massachusetts at $141k per year — 0% above the prevailing wage of $141k. The case was certified in 30 days during the FY FY2025 cycle. This position is for continued employment.
| Case Number | I-200-25022-634122 |
| Case Status | Certified - Withdrawn |
| Visa Class | H-1B |
| Fiscal Year | FY 2025 |
| Employer | Ultragenyx Pharmaceutical, Inc. |
| Employer Location | Novato, California |
| Job Title | Assoc. Director, Technical Project Management - Gene Therapy |
| SOC Code | 11-912100 – Natural Sciences Managers |
| Worksite | Bedford, Massachusetts |
| Annual Wage | $141k |
| Prevailing Wage | $141k |
| Wage Premium | 0.0% |
| Positions | 1 (0 new, 1 continued) |
| Job Title | Salary | Status | Date |
|---|---|---|---|
| Senior Research Associate I | $89k | CERTIFIED | Apr 6, 2025 |
| Manager, Quality Assurance | $125k | CERTIFIED | Apr 6, 2025 |
| Senior Director, Regulatory Affairs | $211k | CERTIFIED | Mar 17, 2025 |
| Associate Director, Quality Assurance Operations Downstream | $177k | CERTIFIED | Feb 26, 2025 |
| Associate Director, Quality Control Systems | $177k | WITHDRAWN | Feb 24, 2025 |
This Labor Condition Application (LCA) was filed by Ultragenyx Pharmaceutical, Inc. for the position of Assoc. Director, Technical Project Management - Gene Therapy in Bedford, Massachusetts. The offered annual salary is $141k, compared to the prevailing wage of $141k for this occupation and location. This represents a wage premium of 0.0% above the prevailing wage.
The LCA is the first step in the H-1B visa process. Employers must file an LCA with the Department of Labor certifying that they will pay the foreign worker at least the prevailing wage for the occupation in the area of intended employment. A certified LCA is required before the employer can file an H-1B petition with USCIS.
Case status: Certified - Withdrawn. This means the employer or their representative withdrew the application.
A Labor Condition Application (LCA) is a mandatory document that U.S. employers must file with the U.S. Department of Labor (DOL) before they can petition for a foreign worker under the H-1B, H-1B1, or E-3 visa categories. The LCA process was established under the Immigration and Nationality Act (INA) to protect both foreign and domestic workers by ensuring fair wages and working conditions.
When a U.S. company identifies a foreign national to fill a specialty occupation position, they must first obtain DOL certification through the LCA process before filing the H-1B petition (Form I-129) with U.S. Citizenship and Immigration Services (USCIS). In this case, Ultragenyx Pharmaceutical, Inc. filed LCA case number I-200-25022-634122 to sponsor a Assoc. Director, Technical Project Management - Gene Therapy position at their worksite in Bedford, Massachusetts. By filing this LCA, the employer attests to four key conditions: (1) paying the higher of the actual wage or prevailing wage, (2) providing working conditions that will not adversely affect other similarly employed workers, (3) no strike or lockout at the worksite, and (4) providing notice of the filing to the bargaining representative or posting notice at the worksite.
The DOL establishes four wage levels for each occupation and geographic area, representing the progression from entry-level to fully competent workers:
For this filing, the offered wage of $141k compares to the DOL prevailing wage of $141k for Natural Sciences Managers positions in the Bedford, Massachusetts area. The positive wage premium of 0.0% indicates the employer is offering above the DOL-determined average for this occupation and location.
The prevailing wage is the average wage paid to similarly employed workers in a specific occupation in the area of intended employment. The DOL determines prevailing wages using data from the Occupational Employment and Wage Statistics (OEWS) survey conducted by the Bureau of Labor Statistics (BLS). Employers must pay H-1B workers the higher of the prevailing wage or the actual wage paid to other employees in similar positions at the company. This requirement is designed to prevent employers from using H-1B workers to undercut domestic wages.
A "Certified-Withdrawn" status means this LCA was initially certified by the DOL but was later withdrawn by the employer. This can happen for various reasons: the foreign worker may have declined the position, found employment elsewhere, the employer may have decided to refile with updated information, or business conditions may have changed. A withdrawal does not negatively affect the employer's ability to file future LCAs.
This LCA was received by the DOL on Jan 22, 2025 and a decision was rendered on Feb 21, 2025, a processing time of approximately 30 business days. The standard DOL processing time for LCA applications is 7 to 10 business days. This application took longer than the standard timeframe, which may indicate additional review was required.
The offered salary of $141k for this Assoc. Director, Technical Project Management - Gene Therapy position provides a data point for evaluating compensation trends in H-1B visa sponsorship. When reviewing H-1B salary data, consider that wages vary significantly based on geographic location, employer size, industry sector, and the worker's experience level. This position falls under SOC code 11-912100 (Natural Sciences Managers), which standardizes how the Bureau of Labor Statistics classifies occupations across industries. Metropolitan areas like New York, San Francisco, and Seattle typically command higher salaries due to higher costs of living, while positions in smaller markets may offer lower nominal wages but comparable purchasing power.
The offered annual salary for this Assoc. Director, Technical Project Management - Gene Therapy position at Ultragenyx Pharmaceutical, Inc. is $141k. The Department of Labor prevailing wage for this occupation and location is $141k. The offered wage represents a 0.0% premium over the prevailing wage.
This H-1B filing is for a position located in Bedford, Massachusetts. The employing company, Ultragenyx Pharmaceutical, Inc., is headquartered in Novato, California.
This Labor Condition Application is filed under the H-1B visa classification. The H-1B visa is designed for specialty occupation workers who possess at least a bachelor's degree or equivalent in a specific field related to the job.
The employer for this filing is Ultragenyx Pharmaceutical, Inc., located in Novato, California. Ultragenyx Pharmaceutical, Inc. filed this Labor Condition Application (case number I-200-25022-634122) for a Assoc. Director, Technical Project Management - Gene Therapy position during fiscal year FY 2025. View all Ultragenyx Pharmaceutical, Inc. H-1B filings.
Certified-Withdrawn means this LCA was initially certified by the DOL but was subsequently withdrawn by the employer or their authorized representative.